- Type / Class
- Equity / Common Stock
- Shares outstanding
- 385,156,449
- Total 13F shares
- 369,281,709
- Share change
- +410,257
- Total reported value
- $42,884,123,591
- Put/Call ratio
- 106%
- Price per share
- $116.18
- Number of holders
- 891
- Value change
- +$52,677,258
- Number of buys
- 413
- Number of sells
- 424
Quarterly Holders Quick Answers
What is CUSIP 252131107?
CUSIP 252131107 identifies DXCM - DEXCOM INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 252131107:
Top shareholders of DXCM - DEXCOM INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
43,819,836
|
$4,962,158,228 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.6%
|
33,189,893
|
$3,758,423,485 | — | 31 Dec 2022 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
4.5%
|
17,302,885
|
$1,959,378,697 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
4.3%
|
16,446,987
|
$1,862,456,808 | — | 31 Dec 2022 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4%
|
15,514,435
|
$1,756,855,000 | — | 31 Dec 2022 | |
| FMR LLC |
13F
|
Company |
2.8%
|
10,952,801
|
$1,240,295,229 | — | 31 Dec 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.8%
|
10,647,096
|
$1,205,678,000 | — | 31 Dec 2022 | |
| Capital Research Global Investors |
13F
|
Company |
2.5%
|
9,461,545
|
$1,071,414,282 | — | 31 Dec 2022 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.4%
|
9,186,222
|
$1,040,247,780 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
8,111,867
|
$916,957,000 | — | 31 Dec 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
2%
|
7,715,970
|
$873,756,000 | — | 31 Dec 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.4%
|
5,315,873
|
$601,969,428 | — | 31 Dec 2022 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
4,919,976
|
$557,138,083 | — | 31 Dec 2022 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1.3%
|
4,815,883
|
$545,350,535 | — | 31 Dec 2022 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
1.1%
|
4,421,427
|
$500,682,357 | — | 31 Dec 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.1%
|
4,327,115
|
$490,002,504 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
4,320,510
|
$489,254,743 | — | 31 Dec 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1%
|
4,033,924
|
$456,802,000 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
3,964,338
|
$448,921,635 | — | 31 Dec 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1%
|
3,890,649
|
$440,577,000 | — | 31 Dec 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1%
|
3,858,870
|
$436,978,439 | — | 31 Dec 2022 | |
| Capital World Investors |
13F
|
Company |
1%
|
3,835,402
|
$434,320,922 | — | 31 Dec 2022 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.98%
|
3,776,775
|
$427,682,000 | — | 31 Dec 2022 | |
| NORGES BANK |
13F
|
Company |
0.97%
|
3,721,104
|
$421,377,817 | — | 31 Dec 2022 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.95%
|
3,658,539
|
$414,293,017 | — | 31 Dec 2022 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.9%
|
3,463,391
|
$392,194,477 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.77%
|
2,984,920
|
$338,012,378 | — | 31 Dec 2022 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.72%
|
2,757,335
|
$312,240,672 | — | 31 Dec 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.69%
|
2,663,484
|
$301,619,351 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.68%
|
2,628,984
|
$297,706,148 | — | 31 Dec 2022 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.66%
|
2,528,413
|
$286,317,488 | — | 31 Dec 2022 | |
| Legal & General Group Plc |
13F
|
Company |
0.64%
|
2,455,166
|
$278,023,088 | — | 31 Dec 2022 | |
| Capital International Investors |
13F
|
Company |
0.6%
|
2,328,733
|
$263,705,725 | — | 31 Dec 2022 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.59%
|
2,267,548
|
$256,777,135 | — | 31 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.58%
|
2,232,844
|
$252,847,254 | — | 31 Dec 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.57%
|
2,192,479
|
$248,276,322 | — | 31 Dec 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.54%
|
2,073,542
|
$234,807,896 | — | 31 Dec 2022 | |
| Ownership Capital B.V. |
13F
|
Company |
0.51%
|
1,956,057
|
$221,503,895 | — | 31 Dec 2022 | |
| AXA S.A. |
13F
|
Company |
0.49%
|
1,887,819
|
$213,776,623 | — | 31 Dec 2022 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.48%
|
1,837,867
|
$208,120,059 | — | 31 Dec 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.47%
|
1,823,554
|
$206,499,255 | — | 31 Dec 2022 | |
| Champlain Investment Partners, LLC |
13F
|
Company |
0.46%
|
1,771,959
|
$200,656,637 | — | 31 Dec 2022 | |
| Amundi |
13F
|
Individual |
0.47%
|
1,802,583
|
$191,362,210 | — | 31 Dec 2022 | |
| Swiss National Bank |
13F
|
Company |
0.41%
|
1,595,600
|
$180,685,744 | — | 31 Dec 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.41%
|
1,590,179
|
$180,070,000 | — | 31 Dec 2022 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.4%
|
1,559,521
|
$176,600,158 | — | 31 Dec 2022 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.39%
|
1,518,447
|
$171,948,938 | — | 31 Dec 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.39%
|
1,495,006
|
$169,294,479 | — | 31 Dec 2022 | |
| Holocene Advisors, LP |
13F
|
Company |
0.36%
|
1,388,398
|
$157,222,190 | — | 31 Dec 2022 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.36%
|
1,379,668
|
$156,234,000 | — | 31 Dec 2022 |
Institutional Holders of DEXCOM INC - Common Stock (DXCM) as of Q1 2023
As of 31 Mar 2023,
DEXCOM INC - Common Stock (DXCM) was held by
891 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
369,281,709 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, FMR LLC, JPMORGAN CHASE & CO, Capital Research Global Investors, GEODE CAPITAL MANAGEMENT, LLC, and Nuveen Asset Management, LLC.
This page lists
892
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
901
Q1 2023 holders
891
Holder diff
-10
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.